TARP Auxiliary Subunits Switch AMPA Receptor Antagonists into Partial Agonists

Quinoxalinedione compounds such as 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) are the most commonly used α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists. However, we find that in the presence of transmembrane AMPA receptor regulatory proteins (TARPs), which are AMPA receptor auxiliary subunits, CNQX acts as a partial agonist. CNQX induced small depolarizing currents in neurons of the central nervous system, and reconstitution of this agonist activity required coexpression of TARPs. A crystal structure of CNQX bound to the TARP-less AMPA receptor ligand-binding domain showed that, although CNQX induces partial domain closure, this movement is not transduced into linker separation, suggesting that TARPs may increase agonist efficacy by strengthening the coupling between domain closure and channel opening. Our results demonstrate that the presence of an auxiliary subunit can determine whether a compound functions as an agonist or antagonist.

[1]  J. Watkins,et al.  Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. , 1990, Trends in pharmacological sciences.

[2]  E. Nielsen,et al.  2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. , 1990, Science.

[3]  M. Mayer,et al.  Structure and function of glutamate receptor ion channels. , 2004, Annual review of physiology.

[4]  D. Wilkin,et al.  Neuron , 2001, Brain Research.

[5]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[6]  B. Sakmann,et al.  Structural determinants of ion flow through recombinant glutamate receptor channels , 1991, Science.

[7]  R. Nicoll,et al.  Auxiliary Subunits Assist AMPA-Type Glutamate Receptors , 2006, Science.

[8]  René H. Levy,et al.  Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII) , 2007, Epilepsy Research.

[9]  M. Mayer,et al.  Tuning activation of the AMPA-sensitive GluR2 ion channel by genetic adjustment of agonist-induced conformational changes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Rogawski.  Molecular targets versus models for new antiepileptic drug discovery , 2006, Epilepsy Research.

[11]  R. Dingledine,et al.  Complex effects of CNQX on CA1 interneurons of the developing rat hippocampus , 2002, Neuropharmacology.

[12]  M. Mayer,et al.  Structural basis for partial agonist action at ionotropic glutamate receptors , 2003, Nature Neuroscience.

[13]  R. Nicoll,et al.  Functional studies and distribution define a family of transmembrane AMPA receptor regulatory proteins , 2003, The Journal of cell biology.

[14]  Kahori Yamada,et al.  Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  I. Tarnawa,et al.  Structure-activity relationships of 2,3-benzodiazepine compounds with glutamate antagonistic action , 1993 .

[16]  M. Fleck,et al.  Targeting AMPA receptor gating processes with allosteric modulators and mutations. , 2007, Biophysical journal.

[17]  R. Dingledine,et al.  CNQX increases spontaneous inhibitory input to CA3 pyramidal neurones in neonatal rat hippocampal slices , 1992, Brain Research.

[18]  B. Sakmann,et al.  Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS , 1995, Neuron.

[19]  P. Osten,et al.  Learning from stargazin: the mouse, the phenotype and the unexpected , 2006, Current Opinion in Neurobiology.

[20]  D. K. Patneau,et al.  Stargazin Modulates Native AMPA Receptor Functional Properties by Two Distinct Mechanisms , 2005, The Journal of Neuroscience.

[21]  S. Traynelis,et al.  Structural aspects of AMPA receptor activation, desensitization and deactivation , 2007, Current Opinion in Neurobiology.

[22]  E. Costa,et al.  Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus. , 1993, Receptors & channels.

[23]  M. Mayer,et al.  Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants. , 1994, Molecular pharmacology.

[24]  E. Ziff.  TARPs and the AMPA Receptor Trafficking Paradox , 2007, Neuron.

[25]  H. Adesnik,et al.  Stargazin modulates AMPA receptor gating and trafficking by distinct domains , 2005, Nature.

[26]  S. Palay,et al.  Cerebellar Cortex: Cytology and Organization , 1974 .

[27]  Allan R. Jones,et al.  Genome-wide atlas of gene expression in the adult mouse brain , 2007, Nature.

[28]  P. Osten,et al.  Stargazin Reduces Desensitization and Slows Deactivation of the AMPA-Type Glutamate Receptors , 2005, The Journal of Neuroscience.

[29]  Burton S. Rosner,et al.  Neuropharmacology , 1958, Nature.

[30]  S N Davies,et al.  Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. , 1988, Science.

[31]  C. Jahr,et al.  Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor-associated glycine binding site. , 1989, Molecular pharmacology.

[32]  M. Farrant,et al.  CNQX increases GABA-mediated synaptic transmission in the cerebellum by an AMPA/kainate receptor-independent mechanism , 2001, Neuropharmacology.

[33]  E. Gouaux,et al.  Mechanisms for Activation and Antagonism of an AMPA-Sensitive Glutamate Receptor Crystal Structures of the GluR2 Ligand Binding Core , 2000, Neuron.

[34]  D. Catarzi,et al.  Competitive AMPA receptor antagonists , 2007, Medicinal research reviews.

[35]  H. Miyakawa,et al.  6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX) increases GABAA receptor-mediated spontaneous postsynaptic currents in the dentate granule cells of rat hippocampal slices , 2004, Neuroscience Letters.